Overall rank by patents
#45,472
of 49,997 tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 2 technology areas, recorded in grant years 2018–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B65B (Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking).
The verdict
According to USPTO PatentsView, Carefusion ranks #45,472 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 2 technology areas.
USPTO PatentsView assignee plate
Corpus R45472 · Foreign Corporation #45,472 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Cardex Systems Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Carefusion Switzerla… · this assignee
43 score
3D Lighting… · lowest
7 score
What this shows Carefusion's Innovation Score is 43.0/100 (top 29% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Carefusion Switzerland 317 SÀRL is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under B65B (Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking). Peak complete grant year is 2023 (2 grants) versus a trough of 1 in 2018. By volume, Carefusion sits between Cardex Systems Inc. and Carpe Diem Technologies, Inc..
Carefusion Switzerland 317 SÀRL shows 3 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Cardex Systems Inc.
5 patents
Cardiosert Ltd.
5 patents
Care Innovations, LLC
5 patents
Carear Holdings LLC
5 patents
Cargotec Research & Development Ireland Limited
5 patents
Carmel Olefins Ltd
5 patents
Carnegie Robotics, LLC
5 patents
Carpe Diem Technologies, Inc.
5 patents
Carefusion Switzerland 317 SÀRL
5 patents
What this shows Carefusion holds 5 patents at rank #45,446, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #45,446 in granted patent volume.
Other assignees with the most granted patents in Carefusion's primary technology class.
Carefusion's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
43 Top 29% higher than 71% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 20.0% |
| 2020 | 1 | 20.0% |
| 2023 | 2 | 40.0% |
| 2024 | 1 | 20.0% |
Top 2 of 2 technology areas
Overall rank by patents
#45,472
of 49,997 tracked assignees
43.0 out of 100
What to do with this data
Carefusion Switzerland 317 SÀRL's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.